益田先生が共著の論文がClinical Lung Cancerに掲載されました。

Clin Lung Cancer. 2024 Dec 9. doi:10.1016/j.jacig.2024.100364.
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)
Masayuki Takeda, Masahide Ota, Eiji Iwama, Shunichi Sugawara, Takehito Shukuya, Shigeki Umemura, Hiroshi Tanaka, Masahide Oki, Takayuki Takahama, Takeshi Masuda, Naoyuki Nogami, Mototsugu Shimokawa.